| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Neuraxis (AMEX:NRXS) is preparing to release its quarterly earnings on Tuesday, 2025-08-12. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Neuraxis to report an earnings per share (EPS) of $-0.19.
The market awaits Neuraxis's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Here's a look at Neuraxis's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | ||||
| EPS Actual | -0.33 | -0.23 | -0.25 | -0.42 |
| Price Change % | -1.0% | 2.0% | 0.0% | 9.0% |
Shares of Neuraxis were trading at $2.46 as of August 08. Over the last 52-week period, shares are down 22.88%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Neuraxis visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: NRXS
